Repligen Corporation to Present at Upcoming Investor Conferences
07 Novembre 2023 - 1:30PM
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused
on bioprocessing technology leadership, today announced that it
will be presenting at two upcoming investor conferences.
- Stifel 2023 Healthcare Conference being
held November 14-15 in New York City. Tony J. Hunt, Chief Executive
Officer, will participate in an analyst-led discussion on
Wednesday, November 15, at 8:00 a.m. ET.
- Stephens’ Annual Investment Conference
being held November 14-16 in Nashville. Tony J. Hunt, Chief
Executive Officer, will participate in an analyst-led discussion on
Thursday, November 16, at 11:00 a.m. ET.
A live webcast of the conference presentations will be
accessible through Repligen’s Investor Relations website at
www.repligen.com, and will be available for replay for a limited
period of time following the event.
About Repligen
CorporationRepligen Corporation is a life sciences tools
and technology company that develops and markets highly innovative
bioprocessing solutions and systems. Our products enable
efficiencies in the process of manufacturing a wide range of
biological drugs, including: monoclonal antibodies; recombinant
proteins; cell and gene therapies; and vaccines. We are inspiring
advances in bioprocessing for the customers we serve around the
globe; primarily biopharmaceutical companies and contract
development and manufacturing organizations (CDMOs). Our corporate
headquarters are located in Waltham, Massachusetts, with additional
administrative and manufacturing operations worldwide. The majority
of our manufacturing sites are located within the U.S. (California,
Massachusetts, New Jersey and New York), and outside of the U.S. we
have sites in Estonia, France, Germany, Ireland, the Netherlands
and Sweden. For more information about the company, see our website
at www.repligen.com and follow us on LinkedIn.
Repligen Contact: Sondra S. NewmanGlobal Head
of Investor Relations(781) 419-1881investors@repligen.com
Repligen (NASDAQ:RGEN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Repligen (NASDAQ:RGEN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024